Literature DB >> 22868967

Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.

A Dupuis, M P Gaub, M Legrain, B Drenou, L Mauvieux, P Lutz, R Herbrecht, S Chan, P Kastner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22868967     DOI： 10.1038/leu.2012.204

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  27 in total

Review 1.  Complementary regulation of early B-lymphoid differentiation by genetic and epigenetic mechanisms.

Authors:  Takafumi Yokota; Takao Sudo; Tomohiko Ishibashi; Yukiko Doi; Michiko Ichii; Kenji Orirani; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2013-09-03       Impact factor: 2.490

2.  Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.

Authors:  J M Boer; A van der Veer; D Rizopoulos; M Fiocco; E Sonneveld; H A de Groot-Kruseman; R P Kuiper; P Hoogerbrugge; M Horstmann; M Zaliova; C Palmi; J Trka; E Fronkova; M Emerenciano; M do Socorro Pombo-de-Oliveira; W Mlynarski; T Szczepanski; K Nebral; A Attarbaschi; N Venn; R Sutton; C J Schwab; A Enshaei; A Vora; M Stanulla; M Schrappe; G Cazzaniga; V Conter; M Zimmermann; A V Moorman; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

3.  Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.

Authors:  Prerana Bhandari; Firoz Ahmad; Bibhu Ranjan Das
Journal:  Med Oncol       Date:  2017-04-11       Impact factor: 3.064

4.  Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma.

Authors:  Yuan Xiao Zhu; Esteban Braggio; Chang-Xin Shi; K Martin Kortuem; Laura A Bruins; Jessica E Schmidt; Xiu-Bao Chang; Paul Langlais; Moulun Luo; Patrick Jedlowski; Betsy LaPlant; Kristina Laumann; Rafael Fonseca; P Leif Bergsagel; Joseph Mikhael; Martha Lacy; Mia D Champion; A Keith Stewart
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

5.  Transcriptional regulation of the Ikzf1 locus.

Authors:  Toshimi Yoshida; Esther Landhuis; Marei Dose; Idit Hazan; Jiangwen Zhang; Taku Naito; Audrey F Jackson; Jeffrey Wu; Elizabeth A Perotti; Christoph Kaufmann; Fotini Gounari; Bruce A Morgan; Katia Georgopoulos
Journal:  Blood       Date:  2013-09-03       Impact factor: 22.113

6.  Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.

Authors:  M Kim; J Park; D-W Kim; Y-J Kim; Y-W Jeon; J-H Yoon; S-H Shin; S-A Yahng; S-E Lee; B-S Cho; K-S Eom; H-J Kim; C-Ki Min; S-G Cho; Y Kim; J-W Lee; K Han; W-S Min; S Lee
Journal:  Bone Marrow Transplant       Date:  2014-12-15       Impact factor: 5.483

7.  Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.

Authors:  Philippe Kastner; Arnaud Dupuis; Marie-Pierre Gaub; Raoul Herbrecht; Patrick Lutz; Susan Chan
Journal:  Am J Blood Res       Date:  2013-01-17

Review 8.  Ikaros fingers on lymphocyte differentiation.

Authors:  Toshimi Yoshida; Katia Georgopoulos
Journal:  Int J Hematol       Date:  2014-08-02       Impact factor: 2.490

9.  Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.

Authors:  Nicholas A Vitanza; Wafik Zaky; Roy Blum; Julia A Meyer; Jinhua Wang; Teena Bhatla; Debra J Morrison; Elizabeth A Raetz; William L Carroll
Journal:  Pediatr Blood Cancer       Date:  2014-06-29       Impact factor: 3.167

10.  Stage-specific control of early B cell development by the transcription factor Ikaros.

Authors:  Tanja A Schwickert; Hiromi Tagoh; Sinan Gültekin; Aleksandar Dakic; Elin Axelsson; Martina Minnich; Anja Ebert; Barbara Werner; Mareike Roth; Luisa Cimmino; Ross A Dickins; Johannes Zuber; Markus Jaritz; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2014-02-09       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.